CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 33 enrolled
Drug / intervention
DeVilbiss AutoAdjust CPAP with revised algorithmdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01797705
NCT01797705N/ACompleted
CompareCT.gov

Revised Algorithm for Next Generation DeVilbiss AutoAdjust CPAP

DeVilbiss Healthcare LLC·interventional·Posted Feb 22, 2013·Updated May 29, 2015

In Brief

A clinical study evaluating DeVilbiss AutoAdjust CPAP with revised algorithm for Obstructive Sleep Apnea. Completed, enrolled 33 participants across 1 site.

Detailed Summary

The purpose of this protocol is to improve the current FDA-approved continuous positive pressure auto-titration algorithm, including treatment precision, residual disease detection characteristics and phenotyping with the DeVilbiss brand AutoAdjust CPAP device.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 22, 2013
Enrollment StartJan 1, 2013
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 13.4 years ago

Interventions

DeVilbiss AutoAdjust CPAP with revised algorithmdevice

Subjects attended a one-night polysomnogram (PSG) titration study. DeVilbiss AutoAdjust CPAP with a revised algorithm was compared to hand-scored PSG to determine whether the machine results were equivalent to hand scores. Each subject acted as their own control for assessing accuracy of sleep event analysis and prescribed CPAP pressure.